Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)

Design and rationale

David J. Whellan, Christopher M. O'Connor, Kerry L. Lee, Steven J. Keteyian, Lawton S. Cooper, Stephen J. Ellis, Eric S. Leifer, William E. Kraus, Dalane W. Kitzman, James A. Blumenthal, David S. Rendall, Nancy Houston-Miller, Jerome L. Fleg, Kevin A. Schulman, Ileana L. Pina

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

Background: Although there are limited clinical data to support the use of exercise training as a means to reduce mortality and morbidity in patients with heart failure, current guidelines state that exercise is beneficial. Trial Design: The objective of this trial is to determine whether exercise training reduces all-cause mortality or all-cause hospitalization for patients with left ventricular systolic dysfunction and heart failure symptoms. After undergoing baseline assessments to determine whether they can safely exercise, patients are randomized to either usual care or exercise training. Patients in the exercise training arm attend 36 supervised facility-based exercise training sessions. Exercise modalities are cycling or walking. After completing 18 sessions, patients initiate home-based exercise and then transition to solely home-based exercise after completing all 36 sessions. Patients return for facility-based training every 3 months to reinforce their exercise training program. Patients are followed for up to 4 years. Physiologic, quality-of-life, and economic end points that characterize the effect of exercise training in this patient population will be measured at baseline and at intervals throughout the trial. Blood samples will be collected to examine biomarkers such as brain natriuretic peptide, tumor necrosis factor, and C-reactive protein. Conclusions: Because of its relatively low cost, high availability, and ease of use, exercise training is an intervention that could be accessible to most patients with heart failure. The HF-ACTION trial is designed to definitively assess the effect of exercise training on the clinically relevant end points of mortality, hospitalization, and quality of life in patients with heart failure.

Original languageEnglish (US)
Pages (from-to)201-211
Number of pages11
JournalAmerican Heart Journal
Volume153
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Heart Failure
Exercise
Mortality
Hospitalization
Lymphotoxin-beta
Quality of Life
Systolic Heart Failure
Brain Natriuretic Peptide
Left Ventricular Dysfunction
C-Reactive Protein
Walking
Biomarkers
Economics
Guidelines
Morbidity
Education
Costs and Cost Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) : Design and rationale. / Whellan, David J.; O'Connor, Christopher M.; Lee, Kerry L.; Keteyian, Steven J.; Cooper, Lawton S.; Ellis, Stephen J.; Leifer, Eric S.; Kraus, William E.; Kitzman, Dalane W.; Blumenthal, James A.; Rendall, David S.; Houston-Miller, Nancy; Fleg, Jerome L.; Schulman, Kevin A.; Pina, Ileana L.

In: American Heart Journal, Vol. 153, No. 2, 02.2007, p. 201-211.

Research output: Contribution to journalArticle

Whellan, DJ, O'Connor, CM, Lee, KL, Keteyian, SJ, Cooper, LS, Ellis, SJ, Leifer, ES, Kraus, WE, Kitzman, DW, Blumenthal, JA, Rendall, DS, Houston-Miller, N, Fleg, JL, Schulman, KA & Pina, IL 2007, 'Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION): Design and rationale', American Heart Journal, vol. 153, no. 2, pp. 201-211. https://doi.org/10.1016/j.ahj.2006.11.007
Whellan, David J. ; O'Connor, Christopher M. ; Lee, Kerry L. ; Keteyian, Steven J. ; Cooper, Lawton S. ; Ellis, Stephen J. ; Leifer, Eric S. ; Kraus, William E. ; Kitzman, Dalane W. ; Blumenthal, James A. ; Rendall, David S. ; Houston-Miller, Nancy ; Fleg, Jerome L. ; Schulman, Kevin A. ; Pina, Ileana L. / Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) : Design and rationale. In: American Heart Journal. 2007 ; Vol. 153, No. 2. pp. 201-211.
@article{9a2cef50d46f478a9bf0956f17feaaca,
title = "Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION): Design and rationale",
abstract = "Background: Although there are limited clinical data to support the use of exercise training as a means to reduce mortality and morbidity in patients with heart failure, current guidelines state that exercise is beneficial. Trial Design: The objective of this trial is to determine whether exercise training reduces all-cause mortality or all-cause hospitalization for patients with left ventricular systolic dysfunction and heart failure symptoms. After undergoing baseline assessments to determine whether they can safely exercise, patients are randomized to either usual care or exercise training. Patients in the exercise training arm attend 36 supervised facility-based exercise training sessions. Exercise modalities are cycling or walking. After completing 18 sessions, patients initiate home-based exercise and then transition to solely home-based exercise after completing all 36 sessions. Patients return for facility-based training every 3 months to reinforce their exercise training program. Patients are followed for up to 4 years. Physiologic, quality-of-life, and economic end points that characterize the effect of exercise training in this patient population will be measured at baseline and at intervals throughout the trial. Blood samples will be collected to examine biomarkers such as brain natriuretic peptide, tumor necrosis factor, and C-reactive protein. Conclusions: Because of its relatively low cost, high availability, and ease of use, exercise training is an intervention that could be accessible to most patients with heart failure. The HF-ACTION trial is designed to definitively assess the effect of exercise training on the clinically relevant end points of mortality, hospitalization, and quality of life in patients with heart failure.",
author = "Whellan, {David J.} and O'Connor, {Christopher M.} and Lee, {Kerry L.} and Keteyian, {Steven J.} and Cooper, {Lawton S.} and Ellis, {Stephen J.} and Leifer, {Eric S.} and Kraus, {William E.} and Kitzman, {Dalane W.} and Blumenthal, {James A.} and Rendall, {David S.} and Nancy Houston-Miller and Fleg, {Jerome L.} and Schulman, {Kevin A.} and Pina, {Ileana L.}",
year = "2007",
month = "2",
doi = "10.1016/j.ahj.2006.11.007",
language = "English (US)",
volume = "153",
pages = "201--211",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)

T2 - Design and rationale

AU - Whellan, David J.

AU - O'Connor, Christopher M.

AU - Lee, Kerry L.

AU - Keteyian, Steven J.

AU - Cooper, Lawton S.

AU - Ellis, Stephen J.

AU - Leifer, Eric S.

AU - Kraus, William E.

AU - Kitzman, Dalane W.

AU - Blumenthal, James A.

AU - Rendall, David S.

AU - Houston-Miller, Nancy

AU - Fleg, Jerome L.

AU - Schulman, Kevin A.

AU - Pina, Ileana L.

PY - 2007/2

Y1 - 2007/2

N2 - Background: Although there are limited clinical data to support the use of exercise training as a means to reduce mortality and morbidity in patients with heart failure, current guidelines state that exercise is beneficial. Trial Design: The objective of this trial is to determine whether exercise training reduces all-cause mortality or all-cause hospitalization for patients with left ventricular systolic dysfunction and heart failure symptoms. After undergoing baseline assessments to determine whether they can safely exercise, patients are randomized to either usual care or exercise training. Patients in the exercise training arm attend 36 supervised facility-based exercise training sessions. Exercise modalities are cycling or walking. After completing 18 sessions, patients initiate home-based exercise and then transition to solely home-based exercise after completing all 36 sessions. Patients return for facility-based training every 3 months to reinforce their exercise training program. Patients are followed for up to 4 years. Physiologic, quality-of-life, and economic end points that characterize the effect of exercise training in this patient population will be measured at baseline and at intervals throughout the trial. Blood samples will be collected to examine biomarkers such as brain natriuretic peptide, tumor necrosis factor, and C-reactive protein. Conclusions: Because of its relatively low cost, high availability, and ease of use, exercise training is an intervention that could be accessible to most patients with heart failure. The HF-ACTION trial is designed to definitively assess the effect of exercise training on the clinically relevant end points of mortality, hospitalization, and quality of life in patients with heart failure.

AB - Background: Although there are limited clinical data to support the use of exercise training as a means to reduce mortality and morbidity in patients with heart failure, current guidelines state that exercise is beneficial. Trial Design: The objective of this trial is to determine whether exercise training reduces all-cause mortality or all-cause hospitalization for patients with left ventricular systolic dysfunction and heart failure symptoms. After undergoing baseline assessments to determine whether they can safely exercise, patients are randomized to either usual care or exercise training. Patients in the exercise training arm attend 36 supervised facility-based exercise training sessions. Exercise modalities are cycling or walking. After completing 18 sessions, patients initiate home-based exercise and then transition to solely home-based exercise after completing all 36 sessions. Patients return for facility-based training every 3 months to reinforce their exercise training program. Patients are followed for up to 4 years. Physiologic, quality-of-life, and economic end points that characterize the effect of exercise training in this patient population will be measured at baseline and at intervals throughout the trial. Blood samples will be collected to examine biomarkers such as brain natriuretic peptide, tumor necrosis factor, and C-reactive protein. Conclusions: Because of its relatively low cost, high availability, and ease of use, exercise training is an intervention that could be accessible to most patients with heart failure. The HF-ACTION trial is designed to definitively assess the effect of exercise training on the clinically relevant end points of mortality, hospitalization, and quality of life in patients with heart failure.

UR - http://www.scopus.com/inward/record.url?scp=33846263440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846263440&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2006.11.007

DO - 10.1016/j.ahj.2006.11.007

M3 - Article

VL - 153

SP - 201

EP - 211

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 2

ER -